Welcome to our dedicated page for Bruker news (Ticker: BRKR), a resource for investors and traders seeking the latest updates and insights on Bruker stock.
Bruker Corporation develops high-performance scientific instruments and analytical and diagnostic solutions for life science, applied, biopharma, microscopy, nanoanalysis, industrial, cleantech and semiconductor metrology markets.
Recurring news for BRKR includes earnings updates for Bruker Scientific Instruments and Bruker Energy & Supercon Technologies, product launches across NMR, microbiology, infection diagnostics, spatial biology and AFM-IR spectroscopy, and governance changes. Company announcements also cover platforms such as MALDI Biotyper, IR Biotyper, MyGenius PRO, GeoMx, CellScape, CosMx and Dimension IconIR.
Summary not available.
Bruker Corporation (Nasdaq: BRKR) has acquired the Integrated Proteomics Pipeline (IP2) developed by Integrated Proteomics Applications Inc. This acquisition enhances Bruker's bioinformatics capabilities, supporting its innovative CCS-enabled 4D-Proteomics™. The IP2 allows fast, scalable data processing, increasing confidence in protein identification and quantification. Bruker will establish a San Diego-based bioinformatics team led by Robin Park, enhancing collaborations with the Yates Lab. Financial terms of the acquisition remain undisclosed.